REQUEST A DEMO
Total
USD $0.00
Search more companies

Arlak Biotech Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Arlak Biotech Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Arlak Biotech Private Limited is an unlisted company, incorporated on 27/04/2007. It has its registered office in the State of Punjab, India. Company's corporate identification number (CIN) is U24232PB2007PTC031093 and registration number is 031093. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Sco No.6, Wadhawa Nagar Near Sunpark Hotel, Dhakoli
Mohali; Punjab; Postal Code: 140603

Contact Details: Purchase the Arlak Biotech Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Arlak Biotech Private Limited report to view the information.
Outstanding Shares:
Purchase the Arlak Biotech Private Limited report to view the information.
Registered Capital:
Purchase the Arlak Biotech Private Limited report to view the information.
Incorporation Date:
April 27, 2007
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
15%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Arlak Biotech Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
24.79%
Total operating revenue
24.79%
Operating profit (EBIT)
54.06%
EBITDA
38.84%
Net Profit (Loss) for the Period
56.63%
Total assets
11.35%
Total equity
18.92%
Operating Profit Margin (ROS)
0.37%
Net Profit Margin
0.29%
Return on Equity (ROE)
3.83%
Debt to Equity Ratio
-14.32%
Quick Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?